XML 41 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
Financial Instruments Measured at Fair Value (Tables)
9 Months Ended
Sep. 29, 2018
Fair Value Disclosures [Abstract]  
Description of Types of Interest Rate Fair Value Hedging Instruments Used The terms of our outstanding interest rate swap contracts at September 29, 2018 are as follows:
Maturity Date
 
Notional Amount
 
Interest rate due from counterparty
 
Interest rate due to counterparty
April 2020
 
50,000
 
6.000%
 
6 mo. USD LIBOR + 3.896%
Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis Table [Text Block] The following table presents assets (liabilities) measured at fair value on a recurring basis at September 29, 2018:
 
 
Balance Sheet
Location
 
Level 1
 
Level 2
 
Level 3
 
Total
Cash equivalents (a)
 
Cash and cash equivalents/
other assets
 
$
17,501

 
$

 
$

 
$
17,501

Equity investments (b)
 
Other assets
 
44,068

 

 

 
44,068

Interest rate swaps
 
Other liabilities
 

 
(864
)
 

 
(864
)
Foreign exchange contracts
 
Other current assets
 

 
3,248

 

 
3,248

Foreign exchange contracts
 
Accrued expenses
 

 
(2,955
)
 

 
(2,955
)
 
 
 
 
$
61,569

 
$
(571
)
 
$

 
$
60,998


The following table presents assets (liabilities) measured at fair value on a recurring basis at December 31, 2017:
 
 
Balance Sheet
Location
 
Level 1
 
Level 2
 
Level 3
 
Total
Cash equivalents (c)
 
Cash and cash equivalents/
other assets
 
$
3,267

 
$
286,671

 
$

 
$
289,938

Equity investments (b)
 
Other assets
 
52,683

 

 

 
52,683

Interest rate swaps
 
Other liabilities
 

 
(149
)
 

 
(149
)
Foreign exchange contracts
 
Other current assets
 

 
5,499

 

 
5,499

Foreign exchange contracts
 
Accrued expenses
 

 
(8,581
)
 

 
(8,581
)
Contingent consideration
 
Accrued expenses
 

 

 
(3,176
)
 
(3,176
)
 
 
 
 
$
55,950

 
$
283,440

 
$
(3,176
)
 
$
336,214


(a)
Cash equivalents include highly liquid investments with an original maturity of less than three months.
(b)
The company has an 8.4% equity ownership interest in Marubun Corporation and a portfolio of mutual funds with quoted market prices. The company recorded an unrealized gain of $222 and an unrealized loss of $6,908 for the third quarter and first nine months of 2018, respectively, on equity securities held at September 29, 2018.
(c)
Cash equivalents at December 31, 2017 included $286,671 invested in certificates of deposit, with an original maturity of less than three months, held in anticipation of our acquisition of eInfochips, which closed in January 2018 (see Note D).
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Text Block] The effects of derivative instruments on the company's consolidated statements of operations and other comprehensive income are as follows:
  
 
Quarter Ended
 
Nine Months Ended
 
 
September 29,
2018

September 30,
2017
 
September 29,
2018
 
September 30,
2017
Gain (Loss) Recognized in Consolidated Net Income
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
$
3,565

 
$
(4,283
)
 
$
4,083

 
$
(15,445
)
Interest rate swaps
 
(311
)
 
(210
)
 
(922
)
 
(532
)
Total
 
$
3,254

 
$
(4,493
)
 
$
3,161

 
$
(15,977
)
Gain (Loss) Recognized in Other Comprehensive Income before reclassifications
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
$
(1,212
)
 
$
(374
)
 
$
(2,348
)
 
$
(1,241
)
Interest rate swaps
 
$

 
$
(3,619
)
 
$

 
$
(4,672
)